Anixa Biosciences News - ANIX

Company Name	Stock Ticker Symbol	Market	Type
Anixa Biosciences Inc	ANIX	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.20	6.71%	3.18	07:32:20

Open Price	Low Price	High Price	Close Price	Prev Close
				2.98

more quote information »

Recent News

Date	Time	Source	Heading
4/25/2024	8:52	IHNW	FeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
4/18/2024	08:20	PRNUS	Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay..
3/14/2024	08:45	PRNUS	Anixa Biosciences 2024 Annual Meeting of Stockholders to..
3/11/2024	08:00	PRNUS	Anixa Biosciences Announces Presentation at 24th Annual..
2/12/2024	07:30	PRNUS	Anixa Biosciences Initiates Dosing in Second Cohort of..
2/08/2024	16:15	EDGAR2	Form DEF 14A - Other definitive proxy statements
1/29/2024	08:50	PRNUS	Anixa Biosciences Announces Participation in 2024..
1/23/2024	07:55	PRNUS	Anixa Biosciences Announces Japanese Patent on Ovarian..
1/16/2024	19:08	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/16/2024	19:07	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/16/2024	19:07	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/16/2024	19:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/16/2024	19:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/16/2024	17:29	EDGAR2	Form SC 13D/A - General statement of acquisition of..
1/16/2024	16:43	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
1/16/2024	16:30	EDGAR2	Form 10-K - Annual report [Section 13 and 15(d), not S-K..
1/10/2024	09:00	PRNUS	Anixa Biosciences to Present at Sidoti Micro-Cap Virtual..
12/14/2023	07:15	PRNUS	Anixa Biosciences to Present at Biotech Showcase 2024
12/07/2023	06:01	EDGAR2	Form 8-K - Current report
12/06/2023	18:00	PRNUS	Anixa Biosciences and Cleveland Clinic Present Positive New..
12/06/2023	16:05	PRNUS	Anixa Biosciences to Host Conference Call This Evening to..
11/27/2023	08:30	PRNUS	Anixa Biosciences Announces European Patent on Ovarian..
11/02/2023	10:58	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/31/2023	08:30	PRNUS	Anixa Biosciences to Present at the Ovarian Cancer Research..
10/23/2023	08:30	PRNUS	Anixa Biosciences Appoints Accomplished Medical Oncologist..
10/13/2023	08:30	PRNUS	Anixa Biosciences Completes Treatment of First Patient..
10/11/2023	10:35	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/03/2023	08:30	PRNUS	Anixa Biosciences Announces Issuance of Additional U.S...
9/19/2023	08:30	PRNUS	Anixa Biosciences Establishes Cancer Business Advisory Board
9/06/2023	16:15	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/31/2023	08:30	PRNUS	Anixa Biosciences to Participate in September Investor..
8/28/2023	08:30	PRNUS	Anixa Biosciences Announces Treatment of Third Patient in..
8/14/2023	08:30	PRNUS	Anixa Biosciences Announces Invited Presentation on Ovarian..
8/07/2023	08:30	PRNUS	Anixa Biosciences Announces Opening of Enrollment for..
7/31/2023	18:36	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/31/2023	18:34	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/27/2023	08:30	PRNUS	Anixa Biosciences Announces Notice of Allowance of..
7/21/2023	10:06	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/11/2023	08:30	PRNUS	Anixa Biosciences Announces Issuance of Canadian Patent for..
5/22/2023	08:30	PRNUS	Anixa Biosciences Announces Treatment of Second Patient in..